Clinical Trial Update: A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on an experimental chemotherapy combination for hormone refractory prostate cancer; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• an experimental chemotherapy combination

Snippet

Sponsor: Eli Lilly and Company | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-04-03